FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Margareta Blombäck

Research Profile

Chemicals & Drugs

Physiology

Procedures

Anatomy

Thrombosis

Disorders

Co-author Network

Publications

TOP 3
Shu He; Kjell Hultenby; Hans Johnsson; Michal Zabczyk; Honglie Cao; Margareta Blombäck
A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor.
Shu He; Håkan Wallèn; Niklas Bark; Margareta Blombäck
In vitro studies using a global hemostasis assay to examine the anticoagulation effects in plasma by the direct thrombin inhibitors: dabigatran and argatroban.
Margareta Blombäck; C Denis; J Eikenboom; D Lane; D Lillicrap
von Willebrand disease biology.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Margareta Blombäck (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Shu He; Kjell Hultenby; Hans Johnsson; Michal Zabczyk; Honglie Cao; Margareta Blombäck
A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor.
British journal of haematology 2013;160(6):806-16.
2013: Shu He; Håkan Wallèn; Niklas Bark; Margareta Blombäck
In vitro studies using a global hemostasis assay to examine the anticoagulation effects in plasma by the direct thrombin inhibitors: dabigatran and argatroban.
Journal of thrombosis and thrombolysis 2013;35(2):131-9.
2012: Margareta Blombäck; C Denis; J Eikenboom; D Lane; D Lillicrap
von Willebrand disease biology.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18 Suppl 4():141-7.
2012: Karin Leander; Håkan Wallén; Margareta Blombäck; Shu He
Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction.
Thrombosis and haemostasis 2012;107(6):1092-9.
2012: Jan Svensson; Håkan Wallén; Ulf Adamson; Ann-Charlotte Bergman; Margareta Blombäck; Gun Jörneskog
Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study.
Biochemical and biophysical research communications 2012;421(2):335-42.
2011: Mika Skeppholm; Margareta Blombäck; Anders Kallner; Karin Malmqvist; Håkan Wallén
Is fibrin formation and thrombin generation increased during and after an acute coronary syndrome?
Thrombosis research 2011;128(5):483-9.
2011: Margareta Blombäck; Shu He; Niklas Bark; Håkan N Wallen; Margareta Elg
Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate.
British journal of haematology 2011;152(6):758-65.
2011: Eli Westerlund; Aleksandra Antovic; Outi Hovatta; Karin P Eberg; Margareta Blombäck; Håkan Wallén; Peter Henriksson
Changes in von Willebrand factor and ADAMTS13 during IVF.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2011;22(2):127-31.
2011: E Rooth; N H Wallen; Margareta Blombäck; Shu He
Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke.
Thrombosis research 2011;127(1):51-6.
2010: Margareta Blombäck
Molecular aspects in clinical hemostasis research at Karolinska Institutet.
Biochemical and biophysical research communications 2010;396(1):131-4.
2010: Shu He; Margareta Blombäck; Niklas Bark; H Johnsson; N Håkan Wallén
The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis.
Thrombosis and haemostasis 2010;103(5):1076-84.
2009: Mika Skeppholm; Anders Kallner; Majid Kalani; Gun Jörneskog; Margareta Blombäck; Håkan N Wallén
ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(8):619-26.
2009: Sam Schulman; A Eelde; Margareta Blombäck; J Stenflo
The plasma concentration of activated protein C appears normal in patients with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(2):566-70.
2009: Shu He; Niklas Bark; Haiyao Wang; Jan Svensson; Margareta Blombäck
Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
Journal of cardiovascular pharmacology 2009;53(1):24-9.
2008: Mika Skeppholm; N Håkan Wallén; Margareta Blombäck; Anders Kallner
Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations?
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(8):1175-9.
2007: Michael Nekludov; Bo-Michael Bellander; Margareta Blombäck; Håkan N Wallen
Platelet dysfunction in patients with severe traumatic brain injury.
Journal of neurotrauma 2007;24(11):1699-706.
2007: Shu He; Kun Zhu; Mika Skeppholm; Jenny Vedin; Jan Svensson; Nils Egberg; Margareta Blombäck; Håkan N Wallen
A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma.
Thrombosis and haemostasis 2007;98(4):871-82.
2007: Margareta Blombäck
Thrombosis and haemostasis research: stimulating, hard work and fun.
Thrombosis and haemostasis 2007;98(1):8-15.
2007: Elisabeth Rooth; Håkan N Wallen; Aleksandra Antovic; Magnus von Arbin; Georgios Kaponides; Nils Gunnar Wahlgren; Margareta Blombäck; Jovan P Antovic
Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(4):365-70.
2007: Margareta Blombäck; B A Konkle; M J Manco-Johnson; Katarina Bremme; M Hellgren; R Kaaja
Preanalytical conditions that affect coagulation testing, including hormonal status and therapy.
Journal of thrombosis and haemostasis : JTH 2007;5(4):855-8.
2007: Nailin Li; Shu He; Margareta Blombäck; Paul Hjemdahl
Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(2):407-13.
2007: Majid Kalani; Angela Silveira; Margareta Blombäck; Jan Apelqvist; Björn Eliasson; Jan W Eriksson; Bengt Fagrell; Ole Torffvit; Anders Hamsten; Gun Jörneskog
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.
Thrombosis research 2007;120(5):653-61.
2007: Michael Nekludov; Jovan P Antovic; Sixten Bredbacka; Margareta Blombäck
Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markers.
Journal of neurotrauma 2007;24(1):174-80.
2005: Aleksandra Antovic; Margareta Blombäck; Margareta Sten-Linder; Pia Petrini; Margareta Holmström; Shu He
Identifying hypocoagulable states with a modified global assay of overall haemostasis potential in plasma.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16(8):585-96.
2005: Anna-Maija Suontaka; A Silveira; T Söderström; Margareta Blombäck
Occurrence of cold activation of transfusion plasma during storage at +4 degrees C.
Vox sanguinis 2005;88(3):172-80.
2005: Aleksandra Antovic; Christina Perneby; G Jacobsson Ekman; Håkan N Wallen; Paul Hjemdahl; Margareta Blombäck; Shu He
Marked increase of fibrin gel permeability with very low dose ASA treatment.
Thrombosis research 2005;116(6):509-17.
2005: Shu He; Honglie Cao; Aleksandra Antovic; Margareta Blombäck
Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16(1):61-7.
2004: Jovan P Antovic; Aleksandra Antovic; Margareta Sten-Linder; ML Wramsby; Margareta Blombäck
Overall hemostatic potential (OHP) assay-a possible tool for determination of prothrombotic pattern in FXII deficiency.
Journal of thrombosis and haemostasis : JTH 2004;2(11):2058-60.
2004: Johanna S Ungerstedt; Jovan P Antovic; Margareta Blombäck; K Bremme; H Johnsson
Antithrombin antigen and activity in patients with acquired antithrombin deficiency-is there a difference?
Journal of thrombosis and haemostasis : JTH 2004;2(5):838-9.
2004: Jovan P Antovic; S Schulman; S S A An; R S Greenfield; Margareta Blombäck
Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?
Scandinavian journal of clinical and laboratory investigation 2004;64(8):745-51.
2003: Aleksandra Antovic; Margareta Blombäck; Katarina Bremme; Marianne van Rooijen; Shu He
Increased hemostasis potential persists in women with previous thromboembolism with or without APC resistance.
Journal of thrombosis and haemostasis : JTH 2003;1(12):2531-5.
2003: Måns Gustaf Edlund; Margareta Blombäck; Shu He
On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(6):593-8.
2003: Jovan P Antovic; Marianne Yngen; Claes-Göran G Ostenson; Aleksandra Antovic; Håkan N Wallen; Gun Jorneskög; Margareta Blombäck
Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(6):551-6.
2003: Majid Kalani; Jan Apelqvist; Margareta Blombäck; Kerstin Brismar; Björn Eliasson; Jan W Eriksson; Bengt Fagrell; Anders Hamsten; Ole Torffvit; Gun Jörneskog
Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
Diabetes care 2003;26(9):2575-80.
2003: Anders Kallner; Nils Egberg; Anna Yu; Rumjana Merzoug-Djilali; Inger Blomberg; Gun Jörneskog; Margareta Blombäck
Are results of fibrinogen measurements transferable?
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(6):804-8.
2003: Shu He; Margareta Blombäck; G Jacobsson Ekman; U Hedner
The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX.
Journal of thrombosis and haemostasis : JTH 2003;1(6):1215-9.
2003: Gun Jörneskog; L-O Hansson; N H Wallen; Marianne Yngen; Margareta Blombäck
Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion.
Journal of thrombosis and haemostasis : JTH 2003;1(6):1195-201.
2003: Anna-Maija Suontaka; Margareta Blombäck; John Chapman
Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light.
Transfusion 2003;43(5):568-75.
2003: Gina Yoo; Margareta Blombäck; Karin Schenck-Gustafsson; Shu He
Decreased levels of von Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocetin-induced platelet aggregation.
British journal of haematology 2003;121(1):123-9.
2003: Johanna S Ungerstedt; Anne Soop; Alf Sollevi; Margareta Blombäck
Bedside monitoring of coagulation activation after challenging healthy volunteers with intravenous endotoxin.
Thrombosis research 2003;111(6):329-34.
2003: Johanna S Ungerstedt; Asa Grenander; Sixten Bredbacka; Margareta Blombäck
Clotting onset time may be a predictor of outcome in human brain injury: a pilot study.
Journal of neurosurgical anesthesiology 2003;15(1):13-8.
2002: Gerd Hall; Margareta Blombäck; Britt Marie Landgren; Katarina Bremme
Effects of vaginally administered high estradiol doses on hormonal pharmacokinetics and hemostasis in postmenopausal women.
Fertility and sterility 2002;78(6):1172-7.
2002: Jovan P Antovic; Aleksandra Antovic; Shu He; L Tengborn; Margareta Blombäck
Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(6):781-6.
2002: Jovan P Antovic; Rangeen Rafik Hamad; Aleksandra Antovic; Margareta Blombäck; Katarina Bremme
Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?
Thrombosis and haemostasis 2002;88(4):644-7.
2002: Jovan P Antovic; Margareta Blombäck
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
Thrombosis research 2002;106(1):59-62.
2002: Måns Gustaf Edlund; Margareta Blombäck; Gabriel Fried
Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(3):225-31.
2002: Aleksandra Antovic; Margareta Blombäck; Katarina Bremme; Shu He
The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(3):181-6.
2002: Jovan P Antovic; M Bakic; M Zivkovic; A Ilic; Margareta Blombäck
Blood coagulation and fibrinolysis in acute ischaemic and haemorrhagic (intracerebral and subarachnoid haemorrhage) stroke: does decreased plasmin inhibitor indicate increased fibrinolysis in subarachnoid haemorrhage compared to other types of stroke?
Scandinavian journal of clinical and laboratory investigation 2002;62(3):195-9.
2002: Johanna S Ungerstedt; Anders Kallner; Margareta Blombäck
Measurement of blood and plasma coagulation time using free oscillating rheometry.
Scandinavian journal of clinical and laboratory investigation 2002;62(2):135-40.
2001: Shu He; Katarina Bremme; Angela Silveira; Marianne van Rooijen; Margareta Blombäck
Hypercoagulation in surgical postmenopausal women having hormone replacement with overdose estradiol.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(8):677-81.
2001: Jovan P Antovic; S Schulman; A Eelde; Margareta Blombäck
Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia 2001;7(6):557-60.
2001: Jovan P Antovic; J Söderström; B Karlman; Margareta Blombäck
Evaluation of a new immunoturbidimetric test (Liatest antithrombin III) for determination of antithrombin antigen.
Clinical and laboratory haematology 2001;23(5):313-6.
2001: Jovan P Antovic; M Bakic; R Milicevic; G Gojkovic; Margareta Blombäck
Activation of the coagulation system occurs within rather than outside cutaneous haemangiomas.
Acta paediatrica (Oslo, Norway : 1992) 2001;90(10):1137-40.
2001: Shu He; Aleksandra Antovic; Margareta Blombäck
A simple and rapid laboratory method for determination of haemostasis potential in plasma. II. Modifications for use in routine laboratories and research work.
Thrombosis research 2001;103(5):355-61.
2001: ML Wramsby; Katarina Bremme; Margareta Blombäck
Measurement of activated protein C resistance during menstrual cycle in women with and without the Leiden mutation.
Thrombosis and haemostasis 2001;85(4):614-8.
2001: Katarina Bremme; Marianne van Rooijen; A Yu; Margareta Blombäck
Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(2):149-55.
2001: S He; Margareta Blombäck; G Yoo; R Sinha; A H Henschen-Edman
Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system.
Annals of the New York Academy of Sciences 2001;936():531-5.
2000: K Fatah-Ardalani; P Wallén; L C Petersen; Margareta Blombäck
More porous fibrin gel structure obtained by interaction with Lys-plasminogen than with Glu-plasminogen.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(4):335-42.
2000: ML Wramsby; MI Bokarewa; Margareta Blombäck; A K Bremme
Response to activated protein C during normal menstrual cycle and ovarian stimulation.
Human reproduction (Oxford, England) 2000;15(4):795-7.
2000: H Shu; ML Wramsby; MI Bokarewa; Margareta Blombäck; Katarina Bremme
Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy.
Journal of thrombosis and thrombolysis 2000;9(3):277-81.
1999: S He; Katarina Bremme; Margareta Blombäck
A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results.
Thrombosis research 1999;96(2):145-56.
1999: Rikard Linder; Margareta Blombäck; Nils Egberg; Lars Grip
Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C.
Thrombosis research 1999;95(2):117-25.
1999: Margareta Blombäck
Scientific visits to the Aland Islands.
Haemophilia : the official journal of the World Federation of Hemophilia 1999;5 Suppl 2():12-8.
1999: S He; Katarina Bremme; Margareta Blombäck
Can the laboratory assay of protein C activity assist in monitoring the hemostatic function in pre-eclampsia?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10(3):127-32.
1999: S He; A Silveira; A Hamsten; Margareta Blombäck; Katarina Bremme
Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia.
Thrombosis and haemostasis 1999;81(4):538-42.
1998: Z Zhang; M Eriksson; G Falk; Caroline Graff; S C Presnell; Marjorie S Read; Timothy C Nichols; Margareta Blombäck; M Anvret
Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed.
Antisense & nucleic acid drug development 1998;8(6):531-6.
1998: Margareta Blombäck; Katarina Bremme; M Hellgren; H Lindberg
A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(4):343-50.
1998: Marianne Kristiansson; M Soop; K G Sundqvist; Anne Soop; Anna-Maija Suontaka; Margareta Blombäck
Local vs. systemic immune and haemostatic response to hip arthroplasty.
European journal of anaesthesiology 1998;15(3):260-70.
1998: Margareta Blombäck; Katarina Bremme; M Hellgren; A Siegbahn; H Lindberg
Thromboprophylaxis with low molecular mass heparin, 'Fragmin' (dalteparin), during pregnancy--a longitudinal safety study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(1):1-9.
1997: Z Zhang; M Eriksson; Margareta Blombäck; M Anvret
A new approach to gene therapy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1997;8 Suppl 2():S39-42.
1997: MI Bokarewa; Margareta Blombäck
Combination of activated protein C resistance and antibodies to phospholipids in the development of thrombosis.
Seminars in hematology 1997;34(3):235-43.
1997: Marianne Kristiansson; Anne Soop; K Keisu; M Soop; Anna-Maija Suontaka; Margareta Blombäck
Local wound and systemic coagulation/fibrinolysis responses in hip arthroplasty. Influence of allogeneic and autologous blood transfusion.
Acta orthopaedica Scandinavica 1997;68(3):221-4.
1997: MI Bokarewa; ML Wramsby; Katarina Bremme; Margareta Blombäck
Variability of the response to activated protein C during normal pregnancy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1997;8(4):239-44.
1997: S He; K Bremme; Margareta Blombäck
Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1997;8(4):232-8.
1997: O Andersson; Margareta Blombäck; K Bremme; Håkan Wramsby
Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation.
Thrombosis and haemostasis 1997;77(5):901-4.
1997: MI Bokarewa; G Falk; Katarina Bremme; Margareta Blombäck; Björn Wiman
Search for mutations in the genes for coagulation factors V and VIII with a possible predisposition to activated protein C resistance.
European journal of clinical investigation 1997;27(4):340-5.
1997: Lars Grip; Margareta Blombäck; Nils Egberg; A Olsson; Bertil Svane; M Velander
Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
European heart journal 1997;18(3):443-9.
1997: Margareta Blombäck; T Söderström; T Wahlberg
[European plasma at risk to be eleminated. The prize is too high when compared with the USA].
Läkartidningen 1997;94(1-2):15-6.
1997: Z Zhang; Margareta Blombäck; M Anvret
Understanding von Willebrand's disease from gene defects to the patients.
Journal of internal medicine. Supplement 1997;740():115-9.
1997: Margareta Blombäck; B M Landgren; Y Stiernholm; O Andersson
The effect of progesterone on the haemostatic mechanism.
Thrombosis and haemostasis 1997;77(1):105-8.
1996: Gun Jörneskog; N Egberg; Bengt Fagrell; K Fatah; B Hessel; H Johnsson; K Brismar; Margareta Blombäck
Altered properties of the fibrin gel structure in patients with IDDM.
Diabetologia 1996;39(12):1519-23.
1996: K Fatah; Angela Silveira; Per Tornvall; Fredrik Karpe; Margareta Blombäck; Anders Hamsten
Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age.
Thrombosis and haemostasis 1996;76(4):535-40.
1996: K Fatah; H Beving; A Albåge; T Ivert; Margareta Blombäck
Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?
European heart journal 1996;17(9):1362-6.
1996: Rikard Linder; Lars Grip; E Olason; Margareta Blombäck
Bedside heparin monitoring by activated partial thromboplastin time measured with a dry reagent.
Clinical chemistry 1996;42(9):1488-9.
1996: MI Bokarewa; Katarina Bremme; Margareta Blombäck
Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy.
British journal of haematology 1996;92(2):473-8.
1996: A M Suontaka; O Akerblom; Margareta Blombäck; L Eriksson; Claes F Högman; J M Payrat
Stability of blood coagulation factors and inhibitors in blood drawn into half-strength citrate anticoagulant.
Vox sanguinis 1996;71(2):97-102.
1995: S Williams; K Fatah; T Ivert; Margareta Blombäck
The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(8):718-25.
1995: S He; Katarina Bremme; Margareta Blombäck
Increased blood flow resistance in placental circulation and levels of plasminogen activator inhibitors types 1 and 2 in severe preeclampsia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(8):703-8.
1995: Margareta Blombäck; R Dybkaer; K Jørgensen; H Olesen; S Thorsen
International Society on Thrombosis and Haemostasis (ISTH), and International Union of Pure and Applied Chemistry (IUPAC), Clinical Properties and units in the clinical laboratory sciences. V. Properties and units in thrombosis and haemostasis (recommendation 1995). International Society on Thrombosis and Haemostasis (ISTH) and International Union of Pure and Applied Chemistry (IUPAC),and International Federation of Clinical Chemistry (IFCC).
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1995;33(9):637-60.
1995: MI Bokarewa; G Falk; Margareta Sten-Linder; N Egberg; Margareta Blombäck; Katarina Bremme
Thrombotic risk factors and oral contraception.
The Journal of laboratory and clinical medicine 1995;126(3):294-8.
1995: MI Bokarewa; Margareta Blombäck; Katarina Bremme
Phospholipid antibodies and resistance to activated protein C in women with thrombophilia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(5):417-22.
1995: E Moor; Angela Silveira; F van't Hooft; A M Suontaka; P Eriksson; Margareta Blombäck; Anders Hamsten
Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(5):655-64.
1995: MI Bokarewa; Katarina Bremme; G Falk; Margareta Sten-Linder; N Egberg; Margareta Blombäck
Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene.
Thrombosis research 1995;78(3):193-200.
1995: Peter Båvenholm; A Proudler; Angela Silveira; D Crook; Margareta Blombäck; Ulf de Faire; Anders Hamsten
Relationships of insulin and intact and split proinsulin to haemostatic function in young men with and without coronary artery disease.
Thrombosis and haemostasis 1995;73(4):568-75.
1995: Margareta Blombäck; P Kronlund; B Aberg; K Fatah; L O Hansson; N Egberg; E Moor; Katrina Carlsson
Pathologic fibrin formation and cold-induced clotting of membrane oxygenators during cardiopulmonary bypass.
Journal of cardiothoracic and vascular anesthesia 1995;9(1):34-43.
1994: E Moor; A Hamsten; Margareta Blombäck; I Herzfeld; B Wiman; L Rydén
Haemostatic factors and inhibitors and coronary artery bypass grafting: preoperative alterations and relations to graft occlusion.
Thrombosis and haemostasis 1994;72(3):335-42.
1994: MI Bokarewa; Margareta Blombäck
Heterogeneity of the APC-resistance phenomenon.
Thrombosis research 1994;75(4):395-400.
1994: E Moor; Anders Hamsten; Fredrik Karpe; Peter Båvenholm; Margareta Blombäck; Angela Silveira
Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age.
Thrombosis and haemostasis 1994;71(6):707-12.
1994: Margareta Blombäck; U Abildgaard; A M van den Besselaar; K J Clementson; B Dahlbäck; T Exner; C W Francis; P Gaffney; H Gralnick; L W Hoyer
Nomenclature of quantities and units in thrombosis and haemostasis (recommendation 1993). A Collaborative project of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH/SSC) and the Commission/Committee on Quantities and Units (in Clinical Chemistry) of the International Union of Pure and Applied Chemistry-International Federation of Clinical Chemistry (IUPAC-IFCC/CQU(CC)).
Thrombosis and haemostasis 1994;71(3):375-94.
1994: MI Bokarewa; Margareta Blombäck; N Egberg; S Rosén
A new variant of interaction between phospholipid antibodies and the protein C system.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1994;5(1):37-41.
1993: Graciela Elgue; Margareta Blombäck; Per Olsson; J Riesenfeld
On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Thrombosis and haemostasis 1993;70(2):289-93.
1992: O Akerblom; K Bremme; A L Dackland; K Fatah; A M Suontaka; Margareta Blombäck
Freezing technique and quality of fresh-frozen plasma.
Infusionstherapie und Transfusionsmedizin 1992;19(6):283-7.
1992: K Fatah; Anders Hamsten; B Blombäck; Margareta Blombäck
Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis.
Thrombosis and haemostasis 1992;68(2):130-5.
1992: Margareta Blombäck; P Eneroth; O Andersson; M Anvret
On laboratory problems in diagnosing mild von Willebrand's disease.
American journal of hematology 1992;40(2):117-20.
1992: A M Suontaka; K Bremme; O Akerblom; Margareta Blombäck
Blood component processing technique and plasma quality.
Infusionstherapie und Transfusionsmedizin 1992;19(3):110-4.
1992: J Wallvik; A M Suontaka; Margareta Blombäck
Proteolytic activity during storage of platelets in plasma.
Transfusion medicine (Oxford, England) 1992;2(2):135-42.
1992: Margareta Blombäck
von Willebrand's disease in Scandinavia and on difficulties in diagnosing von Willebrand's disease type I.
Haemostasis 1992;22(5):236-44.
1991: Lars Grip; Margareta Blombäck; S Schulman
Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients.
European heart journal 1991;12(11):1225-33.
1990: Graciela Elgue; B Pasche; Margareta Blombäck; Per Olsson
The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systems.
Thrombosis and haemostasis 1990;63(3):435-8.
1987: K Gréen; Jan Liska; N Egberg; Bansi Koul; B Ljungberg; Margareta Blombäck; O Vesterqvist; B Semb
Hemostatic disturbances associated with implantation of an artificial heart.
Thrombosis research 1987;48(3):349-62.
1987: Margareta Blombäck; H Kjellman; J P Allain; U Hedner; K Schimpf; B Wiechel
On the unreliability of one-stage factor VIII:C clotting assays after infusion of factor VIII concentrates.
Scandinavian journal of clinical and laboratory investigation 1987;47(6):561-6.
1987: Margareta Blombäck; H Kjellman; S Schulman; N Egberg; B Böttiger; B Wiechel
Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up.
Infection 1987;15(4):248-52.
1987: S Schulman; G Biberfeld; Margareta Blombäck; B Böttiger; N Egberg; H Johnsson; B Wiechel
HIV infection in a defined population of Swedish haemophiliacs.
Scandinavian journal of infectious diseases 1987;19(2):159-66.
1985: G Biberfeld; B Böttiger; A Karlsson; E Sandström; L Morfeldt-Månsson; Margareta Blombäck; I M Nilsson; B Wiechel; William Saxinger; Robert C Gallo
HTLV-III infection in homosexuals and hemophiliacs in Sweden.
Cancer research 1985;45(9 Suppl):4609s-4611s.
1982: B Kudryk; D Robinson; C Netré; B Hessel; Margareta Blombäck; B Blombäck
Measurement in human blood of fibrinogen/fibrin fragments containing the B beta 15-42 sequence.
Thrombosis research 1982;25(3):277-91.